LEO Pharma RD

LEO Pharma

Innovative Pharmaceuticals

LEO Pharma is a leader in medical dermatology with a robust R&D pipeline across a wide range of therapies enabling people with severe skin diseases to access medicine and treatment.

Company Background

  • Advancing the science of dermatology with a leading branded topical dermatology franchise based on decades of research and development.
  • Setting new standards of care for people with skin conditions with a global team of about 5,000 people, serving 93 million patients in more than 130 countries.

Vision & Outlook

  • Support LEO Pharma on its journey to strengthening its global leadership in medical dermatology.
  • Help to expand the company's dermatology franchise and to accelerate innovation and growth.

Highlights & Updates

  • Committed to net-zero climate target aligned with SBTi and launched ESG linked financing.
LEO Pharma Logo

SECTOR

Healthcare

REVENUES 2023

EUR 1,520 million

EMPLOYEES

4,285

OWNERSHIP

Fund X

INVESTMENT DATE

2021

HEAD OFFICE

Ballerup, Denmark

MANAGEMENT

Christophe Bourdon

CEO

Philip Eickhoff

CFO

CHAIRPERSON

Jesper Brandgaard

Chair

RESPONISBLE ADVISORS

Raj Shah

Partner | Head of Healthcare | Head of UK

Jonas Agnblad

Partner, Co-Head of Evolution advisory

Nordic Capital's healthcare focus

Nordic Capital is one of the most active and experienced investors in healthcare globally, focusing on investments in companies throughout the healthcare space with potential to grow and expand into new markets and industry-leading innovations or value propositions.

Learn more here: